Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 0
  • RiskGrade: 328
  • Beta: 0.02

Regulatory News

Holding(s) in Company 27-May-2025 15:13 RNS
Notice of AGM 20-May-2025 07:00 RNS
Final Results 19-May-2025 07:00 RNS
Warrant Extension, Debt Conversion & Equity Issue 01-Apr-2025 07:00 RNS
Extension of Warrants in Incanthera to 30 Sep 2025 01-Apr-2025 07:00 RNS
ImmuPharma proves unique Mechanism of Action-P140 13-Mar-2025 07:00 RNS
Holding(s) in Company 21-Feb-2025 11:36 RNS
£2.91m fundraising; related party transacti... 13-Feb-2025 07:00 RNS
Response to Share Price Movement 28-Jan-2025 12:57 RNS
Breakthrough Findings into Autoimmune Diseases 09-Jan-2025 07:00 RNS
Change of Auditor 23-Dec-2024 07:00 RNS
Holding(s) in Company 10-Dec-2024 14:36 RNS
Appointment of Company Secretary 04-Dec-2024 07:00 RNS
Extension of Warrants in Incanthera to 31 Mar 2025 09-Sep-2024 07:01 RNS
Half-year Report 09-Sep-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 3.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 5.90
52 Week Low 1.09
Volume 0
Shares Issued 499.72m
Beta 0.02
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.5% below the market average28.5% below the market average28.5% below the market average28.5% below the market average28.5% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
63.42% above the market average63.42% above the market average63.42% above the market average63.42% above the market average63.42% above the market average
78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
15:18 74,005 @ 2.69p
15:16 39 @ 2.56p
15:05 50,000 @ 2.73p
14:00 330,000 @ 2.72p
14:58 50,000 @ 2.73p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page